Home/Filings/4/0001209191-11-047454
4//SEC Filing

CONWAY PHILIP J 4

Accession 0001209191-11-047454

CIK 0000868368other

Filed

Sep 11, 8:00 PM ET

Accepted

Sep 12, 3:26 PM ET

Size

28.6 KB

Accession

0001209191-11-047454

Insider Transaction Report

Form 4
Period: 2011-09-08
CONWAY PHILIP J
Vice President
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2011-09-0915,0020 total
    Exercise: $2.17Exp: 2011-10-16Common Stock (15,002 underlying)
  • Exercise/Conversion

    Common Stock

    2011-09-08$2.17/sh+2,800$6,062396,943 total
  • Sale

    Common Stock

    2011-09-08$8.03/sh2,800$22,484394,143 total
  • Exercise/Conversion

    Common Stock

    2011-09-09$2.17/sh+17,200$37,238411,343 total
  • Sale

    Common Stock

    2011-09-09$7.85/sh17,200$135,020394,143 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2011-09-082,8002,198 total
    Exercise: $2.17Exp: 2011-10-16Common Stock (4,998 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2011-09-092,1980 total
    Exercise: $2.17Exp: 2011-10-16Common Stock (2,198 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $4.13From: 2004-01-02Exp: 2013-01-02Common Stock (10,000 underlying)
    10,000
  • Common Stock

    (indirect: By Spouse)
    9,600
  • Stock Option (Right to Buy)

    Exercise: $4.63From: 2005-01-02Exp: 2014-01-02Common Stock (12,000 underlying)
    12,000
  • Stock Option (Right to Buy)

    Exercise: $5.70From: 2007-01-26Exp: 2016-01-26Common Stock (20,000 underlying)
    20,000
  • Stock Option (Right to Buy)

    Exercise: $4.70From: 2006-01-01Exp: 2015-01-01Common Stock (30,000 underlying)
    30,000
Footnotes (4)
  • [F1]The price in Column 4 is a weighted average. The prices actually received ranged from $8.00 to $8.05. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F2]The price in Column 4 is a weighted average. The prices actually received ranged from $7.80 to $7.89. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F3]Currently 100% vested.
  • [F4]Vest as to 25% annual cumulative installments beginning one year from date of grant, beginning the date shown.

Issuer

ROCHESTER MEDICAL CORPORATION

CIK 0000868368

Entity typeother

Related Parties

1
  • filerCIK 0001033090

Filing Metadata

Form type
4
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 3:26 PM ET
Size
28.6 KB